Showing 1421-1430 of 1477 results for "".
- GN Corporation: Vision Restored with Corneal Cell Transplant Using a Nano Sheet Techniquehttps://modernod.com/news/gn-corporation-vision-restored-with-corneal-cell-transplant-using-a-nano-sheet-technique/2477121/A novel cell transplantation method to treat corneal endothelial diseases such as bullous keratopathy using a nano-composite gel sheet developed by Japanese scientists was granted Indian patent to GN Corporation (GNC), Japan, according to a company news release. This method was earlier granted a
- Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Programhttps://modernod.com/news/aerie-pharmaceuticals-announces-agreement-to-acquire-avizorex-pharma-to-advance-its-dry-eye-program/2477097/Aerie Pharmaceuticals announced it is acquiring Avizorex Pharma, a Spanish ophthalmic pharmaceutical company developing therapeutics for the treatment of dry eye disease. AVX completed a phase 2a study in dry eye subjects earlier this year with its lead product candidate, AVX-012. The acti
- TECLens Announces Completion of Enrollment of a Pilot Clinical Study for the Treatment of Keratoconushttps://modernod.com/news/teclens-announces-completion-of-enrollment-of-a-pilot-clinical-study-for-the-treatment-of-keratoconus/2476980/TECLens announced the completion of enrollment of its pilot clinical study for the treatment of Keratoconus using the TECLens’ CXLens ‘on-eye’ cross-linking system for corneal remodeling. Clinical trial results are anticipated in early 2020. TECLens’ CXLens will pro
- Report: Chocolate May Not Help Your Visionhttps://modernod.com/news/report-chocolate-may-not-help-your-vision/2476938/In disappointing news for chocolate lovers, researchers have found that contrary to an earlier report, eating dark chocolate will not improve your vision, according to a Reuters report. The earlier report suggested that certain aspects of
- Sight Sciences Raises $56M to Lead the Development of MIGS Market and Procedure-Based Dry Eye Markethttps://modernod.com/news/sight-sciences-raises-56m-to-lead-the-development-of-migs-market-and-procedure-based-dry-eye-market/2476848/Sight Sciences announced the closing of $31 million in Series D Preferred Stock financing. MidCap Financial and Sight Sciences entered into a $25 million debt facility earlier in 2019. The $56 million
- Glaukos Announces Global Licensing Agreement With Intratus, Maker of Noninvasive Drug Delivery Platformhttps://modernod.com/news/glaukos-announces-global-licensing-agreement-with-intratus/2476756/Glaukos announced that it has entered into a licensing agreement with privately held, early-stage life sciences company Intratus. Under terms of the deal, Intratus has granted Glaukos a global exclusive license to
- Aerie Pharmaceuticals Completes Enrollment of the Netarsudil Phase 2 Clinical Trial in Japan Ahead of Schedulehttps://modernod.com/news/aerie-pharmaceuticals-completes-enrollment-of-the-netarsudil-phase-2-clinical-trial-in-japan-ahead-of-schedule/2479568/Aerie Pharmaceuticals announced that enrollment for its phase 2 clinical trial of netarsudil ophthalmic solution in Japan is complete, a milestone reached several months earlier than previously anticipated. The first patients to enter this prospective, double-masked, multicenter, placebo-
- Valeda Light Delivery System Receives 2019 Medical Design Excellence Awardhttps://modernod.com/news/valeda-light-delivery-system-receives-2019-medical-design-excellence-award/2476654/LumiThera and Product Creation Studio announced that LumiThera’s Valeda Light Delivery System has won a silver award in the 21st Annual Medical Design Excellence Awards competition. The 2019 winners were announced at the MDEA Ceremony on Tuesday, June 11, 2
- Presbia Abandons Flexivue Microlens, Lays Off All But 3https://modernod.com/news/presbia-abandons-flexivue-microlens-lays-off-all-but-3/2476501/Presbia said it spiked its Flexivue microlens development program in the face of FDA headwinds, laying off all but three of its employees as it seeks investors to bail it out, according to a Mass Device report. Earlier this month, the Irvine, Calif.-based company
- ARVO Foundation Announces New Mallinckrodt Uveitis Research Fellowshiphttps://modernod.com/news/arvo-foundation-announces-new-mallinckrodt-uveitis-research-fellowship/2476437/The Association for Research in Vision and Ophthalmology (ARVO) announced the launch of a new fellowship for early-career researchers. The Ma